Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.
Eleftheriadou A, Riley D, Zhao SS, Austin P, Hernández G, Lip GYH, Jackson TL, Wilding JPH, Alam U.
Higher levels of circulating ANGPTL2 are associated with macular edema in patients with type 2 diabetes.
Yin R, Zhang N, Zhang D, Zhao W, Ke J, Zhao D.
Medicine (Baltimore). 2021 Feb 12;100(6):e24638. doi: 10.1097/MD.0000000000024638.
PMID:33578584
A dynamic nomogram for predicting diabetic macular edema in type 2 diabetes patients based on plasma cytokines.
Zhang N, Ke J, Zhang D, Zhang Y, Fu Y, Cao B, Zhao D.
Aging (Albany NY). 2021 Mar 3;13(6):8369-8379. doi: 10.18632/aging.202647. Epub 2021 Mar 3.
PMID:33686950
Proteinuria in early referral to spectral domain optical coherence tomography for macular edema detection in type 2 diabetes individuals: results from the Brazilian diabetes study.
Curr Med Res Opin. 2022 Dec;38(12):2141-2148. doi: 10.1080/03007995.2022.2131302. Epub 2022 Nov 4.
PMID:36190762
Development and validation of a simple and practical model for early detection of diabetic macular edema in patients with type 2 diabetes mellitus using easily accessible systemic variables.
Wu G, Hu Y, Zhu Q, Liang A, Du Z, Zheng C, Liang Y, Zheng Y, Hu Y, Kong L, Liang Y, Amadou MLDJ, Fang Y, Liu Y, Feng S, Yuan L, Cao D, Lin J, Yu H.
J Transl Med. 2024 May 31;22(1):523. doi: 10.1186/s12967-024-05328-y.